Severe systemic Bacillus anthracis infection in an intravenous drug user

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Veitch, Jessica ^a   Kansara, Anoushka ^a   Bailey, Daniel ^b   Kustos, Ildiko ^a  

^a Countess of Chester NHS Foundation Trust ^*  (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; CLINDAMYCIN; D DIMER; DIAMORPHINE; VANCOMYCIN;

ABDOMEN; ABDOMINAL PAIN; ADULT; ANTHRAX; ARM; ARTICLE; BIOPSY; BLISTER; CASE REPORT; CELLULITIS; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DETERIORATION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FEVER; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INGUINAL REGION; INTRAVENOUS DRUG ABUSE; KIDNEY FUNCTION; LOADING DRUG DOSE; LYMPHOCYTE COUNT; MALE; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; RASH; SURVIVAL; TACHYCARDIA; TREATMENT DURATION; VACUUM ASSISTED CLOSURE; VOMITING;

EID: 84897017563     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-201921     Document Type: Article

References (12)

1. Hicks CW, Sweeney DA, Cui X, et al. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med 2012; 38:1092-104.
2. Martin GJ, Friedlander AM. 2010. Bacillus anthracis (anthrax). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell Douglas and Bennett's principles and practice of infectious diseases. 7th edn. Churchill Livingston Elsevier 2715-31.
3. Louisiana State University. School of Vetinary Medicine. World anthrax data site, 2003. http://www.vetmed.lsu.edu/whocc/mp-world.htm (accessed 30 Mar 2012).
4. Health Protection Scotland. Interim clinical guidance for the management of suspected anthrax in drug user. http://www.documents.hps.scot.nhs.uk/giz/ anthrax-outbreak/ clinical-guidance-for-use-of-anthrax-immune-globulin-v12-1- 2010-03-19.pdf (accessed 15 Oct 2013).
5. Martin GJ, Friedlander AM. 2010. Anthrax as an agent in bioterrorism. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell Douglas and Bennett's principles and practice of infectious diseases. 7th edn. Churchill Livingston Elsevier, 3983-92.
6. Grunow R, Verbeek L, Jacob D, et al. Injection Anthax?a new outbreak in heroin users. Dtsch Ärztebl Int 2012; 109:843-8.
7. Health Protection Scotland. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team. December 2011. http://www.documents.hps.scot.nhs. uk/ giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf (accessed 15 Oct 2013).
8. Ringertz SH, Høiby EA, Jensenius M, et al. Injectional anthrax in a heroin skin-popper. Lancet 2000; 356:1574-5.
9. Public Health England. Anthrax 2012 outbreak press releases. http://www.hpa.org. uk/webw/HPAweb&Page&HPAwebAutoListName/Page/ 1317135273732 (accessed 15 Oct 2013).
10. Antwerpen MH, Zimmermann P, Bewley K, et al. Real-time PCR system targeting a chromosomal marker specific for Bacillus anthracis. Mol Cell Probes 2008; 22:313-15.
11. Health Protection Scotland and the Health Protection Agency. Clinical presentations of anthrax. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/ 1265637136474 (accessed 15 Oct 2013).
12. Health Protection Agency. Clinical algorithm: clinical evaluation and management of drug users with possible anthrax. http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb-C/1259152399460 (accessed 15 Oct 2013)